1 2 Diversity in host resistance often associates with reduced pathogen spread. This 3 may result from ecological and evolutionary processes, likely with feedback between 4 them. Theory and experiments on bacteria-phage interactions have shown that 5 genetic diversity of the bacterial adaptive immune system can limit phage evolution 6 to overcome resistance. Using the CRISPR-Cas bacterial immune system and lytic 7 phage, we engineered a host-pathogen system with a non-overlapping genetic 8 architecture of infectivity. With this model system, we explored how CRISPR 9 diversity impacts the spread of phage when they can overcome a resistance allele, 10 how immune diversity affects the evolution of the phage to increase its host range, 11
Introduction 35 36
Genetic diversity is a key determinant of the ecology and evolution of host-pathogen 37 systems. Various studies of wild organisms have shown that genetic diversity within 38 a host species often affects pathogen prevalence. The importance of diversity for 39 disease prevalence in wild populations has been observed in numerous species, for 40 example: cheetahs (1); Italian agile frogs (2); crimson rosella parrots (3); inbred 41 black-footed ferret populations (4); inbred California sea lions (5); young island 42 populations of deer mice (6); and Galapagos hawks (7) . The importance of diversity 43 for limiting disease in agricultural contexts has long been recognised (8), for example 44 in rice (9) and hybridising populations of honeybees (10). In laboratory environments, 45 more genetically diverse populations of Daphnia magna are more resistant to 46 parasites (11), an effect that depends on the genetic architecture of resistance (12). 47
In microbial systems, Pseudomonas aeruginosa PA14 and Streptococcus 48 thermophilus with diverse immunity alleles were shown to be more resistant against 49 lytic bacteriophage (13, 14). Two recent meta-analyses have shown that host 50 diversity is a robust defence against pathogens both in agricultural (15) and natural 51 populations (16) . 52
53
The suggested reasons for the effect of host diversity on pathogen spread can be 54 broadly divided into ecological and evolutionary effects. The ecological effect of 55 diversity may manifest through a dilution effect (17, 18) . In terms of within-species 56 immune diversity, increasing the number of resistant or low-quality hosts decreases 57 the fraction of susceptible hosts. This can reduce contact rates between free-living 58 pathogens and susceptible hosts, which in turn limits the basic reproduction number 59 4 of the pathogen (R 0 ) (19-21). There is much observational support for the role of a 60 dilution effect in multi-species host-pathogen systems (reviewed in (18)), and some 61 experimental work has suggested that dilution of susceptible host genotypes can 62 limit pathogen spread in single host species systems (22, 23) . Evolutionary effects of 63 diversity may manifest through limitation of the evolutionary emergence of novel 64 pathogen genotypes (24, 25), potentially because the supply of novel pathogen 65 mutations depends on the prevalence of susceptible hosts (26-28). The evolutionary 66 and ecological effects of host diversity are likely to depend on one another, as the 67 basic reproductive value of a pathogen will influence its ability to evolve to overcome 68 host resistance (27). Further, because increasing host diversity dilutes susceptible 69 hosts, pathogens may reach smaller population sizes and generate fewer novel 70 variants on which selection can act. Simultaneously, increasing host diversity can 71 increase selection for novel variants. These two effects can maximise evolutionary 72 emergence at intermediate host diversity (29, 30) . 73
74
The interaction between lytic bacteriophage (phage) and the bacterial CRISPR-Cas 75 (Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-associated) 76 immune system is a tractable model system to study the evolutionary ecology of 77 infectious diseases, including the role of host diversity (13, 29, 31). CRISPR-Cas 78 immune systems can incorporate short DNA fragments (spacers) of about 30 base 79 pairs derived from the phage genome into CRISPR loci on the host genome (32). 80
Processed CRISPR transcripts guide Cas immune complexes to identify and cleave 81 the invading phage genome, preventing successful re-infections (33-36). In turn, 82 phage can evolve to overcome CRISPR immunity by point mutation in the sequence 83 targeted by the spacer (protospacer) or in the protospacer-adjacent motif (PAM), 84 5 which flanks the protospacer and functions in self/non-self discrimination (37-40). 85 Phage evolution to overcome CRISPR immunity can lead to CRISPR-phage 86 coevolution (41-44). CRISPR loci in both natural and experimental populations can 87 be highly diverse (41, 42, 45, 46) , due to different bacteria in the population acquiring 88 different spacers (31). Diversity has important implications for the coevolutionary 89 interaction, as CRISPR diversity can provide increased resistance by limiting the 90 ability of phage to acquire the mutations needed to overcome CRISPR resistance 91 (41). Phage mutation is limited by mutation supply (47-49), and full phage infectivity 92 requires mutations in all the protospacers targeted by the host CRISPR array. This 93 becomes more difficult as individual-and population-level CRISPR diversity 94 increases (48, 50), and can drive rapid phage extinction (13, 14, 29) . 95 96 Apart from this evolutionary effect, theory predicts that even if a phage mutant 97 evolved that can overcome one CRISPR resistance allele in the population, its ability 98 to amplify will be reduced in a more diverse host population (19). The resulting 99 smaller phage population sizes are in turn predicted to reduce the ability of the 100 phage to evolve to overcome other CRISPR resistance alleles in the population (27, 101 29). However, these predictions remain untested. We therefore set out to explicitly 102 test the ecological role of host diversity and its knock-on evolutionary effects using 103 the bacteria Pseudomonas aeruginosa and its lytic phage DMS3vir. We performed 104 an experiment where we manipulated the degree of CRISPR diversity in the host 105 population by mixing different numbers of CRISPR-resistant clones, and measured 106 host fitness, phage population dynamics and evolution, following infection with a 107 phage that was pre-evolved to infect one CRISPR resistance allele in the population. 108 6 Results 109 110 To explore how population-level immune diversity would influence the population 111 dynamics and evolution of an infective phage and its susceptible host genotype, we 112 set up an experiment where we mixed 1-, 3-, 6-, 12-and 24-clones, and inoculated 113 each treatment with a phage that was pre-evolved to infect only one of the clones 114 (escape phage) ( Figure S1 & S2) . The susceptible clone (i.e. the one that could be 115 infected by the escape phage) always carried a lacZ reporter gene, so we could 116 follow its population dynamics and competitive performance during the experiment. 117 P. aeruginosa ∆ pilA, which only resists phage infection via surface receptor 118 modification, was included in each treatment to provide a benchmark against which 119 the dynamics and performance of the entire CRISPR population could be measured. 120
We also included 1-and 24-clone treatments inoculated with ancestral phage to 121 which the whole bacterial population was resistant, which served as a control (13). 122
We then monitored population dynamics and evolution of the phage, CRISPR clones 123 and the susceptible clone over 3 days. 124
125
We hypothesised that if CRISPR diversity limits phage epidemics, then both phage 126 density and survival would be negatively correlated with CRISPR diversity. Phage 127 densities decreased as CRISPR diversity increased (F 6,342 = 48.30, p < 2.2 x 10 -16 ; 128 observed when an escape phage infects a monoclonal (but susceptible) population 136 ( Fig. 1B) , which is in line with previous data showing that CRISPR-resistant 137 monocultures allow phage persistence due to rapid evolution of escape phage that 138 overcome the CRISPR resistance allele (13). When we explored the model further, 139
we found that ancestral phage titres were lower in the 24-clone population compared 140 to the same treatment with the pre-evolved escape phage (difference in ln pfu ml -1 : β 141 [95% CI] = -2.40 [-4.67, -0.33], t(2) 342 = -2.25, p = 0.03; Fig. 1B ). This is consistent 142 with a modest escape phage epidemic being able to establish by replicating on the 143 susceptible fraction of the host population. 144
145
Next we hypothesised that if phage survival across our CRISPR diversity treatments 146 was related to phage evolution, the proportion of phage that evolved an expanded 147 infectivity range would negatively correlate with CRISPR diversity. Given that our 148 experiment was designed such that the proportion of the host population resistant to 149 the escape phage increased with CRISPR diversity, there would likely have been 150 strong selection to acquire mutations in other protospacers and PAMs to infect other 151 hosts in the population. The evolution of range expansion did depend on diversity 152 (LR = 6.60, p = 0.01), and was most likely in the 6-clone treatment, particularly at 3 153 days post-infection (dpi) (Fig. 2) . This is consistent with the idea that intermediate 154 host diversity maximises evolutionary emergence (29, 30). Phage survival in some 155 treatments was promoted by evolutionary emergence of host shift, where infectivity 156 on the original host is lost but phage evolved to infect a new host. This is a less likely 157 event as it involves two mutations: back-mutation to the ancestral state at the original 158 8 protospacer followed by mutation at the new protospacer, all while incurring the cost 159 of loss of infectivity on the original host. We observed phage in two replicates of the 160 24-clone treatment had evolved via host shift. Sequence data confirmed that single 161 nucleotide polymorphisms (SNPs) in the PAM that conferred infectivity to the original 162 host had been lost, and novel SNPs or deletions had emerged in protospacers that 163 conferred infectivity to a new host present in the population ( Table 4 & 5 in S1 Text). 164
These data suggest that the evolutionary emergence of host range expansion or 165 host shift contributed to phage survival. 166 167 Given that CRISPR diversity negatively affected phage persistence, we reasoned 168 that this could also lead to enhanced fitness of the CRISPR population as a whole 169 (13). We therefore hypothesised that the selection rate (53, 54) of all CRISPR clones 170 (both resistant and susceptible) would be positively related to CRISPR diversity. We 171 did find that CRISPR clones in all polyclonal CRISPR populations had higher 172 selection rates compared to clonal populations during infection with escape phage 173 ( Fig. 3) . However, within the polyclonal populations, we did not detect a relationship 174 between CRISPR diversity and selection rate when controlling for the effect of time 175 (F 4,113 = 1.73, p = 0.15; Fig. 3C ). Selection rate also did not change notably over time 176 were dependent on the susceptible subpopulation. Consequently, we hypothesised 182 that the selection rate of susceptible CRISPR clones would be positively related to 183 9 the level of CRISPR diversity. Indeed, in some replicates in the 3-and 6-clone 184 treatments the susceptible CRISPR clone was driven extinct by phage ( Fig. 4A) . 185
Further, the selection rate of susceptible CRISPR clones in these treatments was on 186 average less than zero (mean selection rate [95% CI]; 3-clone: -1. Previous studies have shown that CRISPR diversity can limit the evolution of phage 204 to overcome host resistance (13, 29). In those studies, bacterial populations were 205 infected with ancestral phage that had not been previously exposed to resistant 206 hosts. Here, we examined the consequences of CRISPR diversity once a phage has 207 already evolved to overcome one of the CRISPR resistance alleles in the population. 208 In theory, this kind of ecological effect can in turn shape the evolutionary dynamics of 222 the bacteria-phage interaction, since smaller phage population sizes will decrease 223 the mutation supply and hence the evolutionary potential of the phage (26-28). We 224 did observe that the evolution of phage host range expansion peaked at intermediate 225 levels of CRISPR diversity. This is likely because increasing CRISPR diversity 226 dilutes susceptible hosts, which results in smaller phage population size and hence 227 less genetic variation on which selection can act. Simultaneously, increasing host 228 diversity can increase selection for escape mutations. These two effects in dynamic 229 tension can maximise evolutionary emergence at intermediate host diversity (29) . 230
231
In this study, we focussed on host populations where different CRISPR resistance 232 genotypes were at equal starting frequencies, but natural communities are often 233 composed of a few very common and many rare variants (57, 58). This likely matters 234 for the observed dynamics, since the proportion of susceptible hosts has a large 235 impact on the probability of evolutionary emergence of pathogens (29). Also, we 236 focussed our analysis on the simple case where a diverse host population is infected 237 by a clonal pathogen population. In nature, pathogen populations will frequently be 238 genetically diverse as well (59, 60), and increased levels of pathogen diversity may 239 affect the benefits of host diversity (61). Indeed, previous studies of CRISPR-phage 240 interactions suggest that infection by two different phages can increase bacteria-241 phage coexistence compared to infections with a single phage (42, 43). The 242 empirical system used in this study offers both a unique ability to link genotypes and 243 phenotypes, tight experimental control over the infectivity matrix of the host-phage 244 interaction, and a clear link with theoretical predictions. These features will make it 245 an ideal system for more detailed studies to understand how the composition of the 246 host population and the relative diversity levels of the phage and host shape 247 coevolutionary interactions. performance of the CRISPR-resistant population as a whole, we also added PA14 280 ∆ pilA (surface mutant; SM, which is fully resistant to phage DMS3vir and has a 281 distinct "smooth" colony morphology) to each mix in equal proportion to the CRISPR 282 population. We then inoculated 6ml of M9m 1:100 from each mix. Approximately 283 1x10 6 pfu ml -1 of the escape phage targeting the labelled BIM were then added to 284 each vial. We also established 1-and 24-clone treatments with ancestral phage as 285 controls. Polyclonal treatments consisted of 8 biological replicates (N=8) to ensure 286 that both BIMs and phage were equally represented across treatments, while the 1-287 clone treatments consisted of 24 biological replicates (N=24). Glass vials were 288 incubated at 37˚C while shaking at 180rpm. At 1, 2, and 3 days-post infection (dpi), 289 the sampling of the phage and bacterial culture was repeated as described. Cultures 290 were transferred 1:100 to fresh media after sampling had been carried out. The 291 experiment was terminated at 3 dpi. 292 293 Each day 180μl of culture was taken from each vial and phage was extracted using 294 chloroform. Phage titres were determined by serially diluting extracted phage in 1x 295 M9 salts, and then spotting 5μl of each dilution on a top lawn of P. aeruginosa PA14 296 csy3::lacZ, which was then incubated at 37˚C for 24hrs. Phage titres were calculated 297 from this assay. The detection limit of phage spot assays is 10 2 pfu ml -1 . To monitor 298 14 bacterial densities, culture samples were serially diluted in 1x M9 salts, and then 299 plated on LB agar + 40µg/ml X-gal + 0.1mM IPTG, and incubated for 48hrs at 37˚C. 300
The density of SM, CRISPR and the labelled BIM was then calculated. SM were 301 differentiated from CRISPR clones by their "smooth" colony morphology, and the 302 We examined phage evolution during the experiment by sampling 12 individual 316 plaques from each replicate that had detectable levels of phage from 1 to 3 dpi, 317 which were amplified on PA14 csy3::lacZ overnight in LB, at 37˚C and shaking at 318 180rpm. Phage were extracted using chloroform, and then diluted 1000-fold. 319
Samples of each phage were then applied on lawns of each of the 24 BIMs and WT 320 PA14 csy3::lacZ. A successful infection was indicated by a clear lysis zone on the 321 top lawn. Phage were classified according to whether they had expanded their 322 infectivity range (could infect the original susceptible clone and a new clone in the 323 15 BIM library). Of the phages that had undergone a host shift (lost infectivity to the 324 original clone and could only infect a new clone), we confirmed their expanded 325 infectivity range by sequencing the old and new protospacers on the evolved phage 326 genome (SourceBioscience, UK). We also sequenced the relevant protospacers of 327 the pre-evolved escape phage from the BIM-phage library and ancestral DMS3vir. 328 Primers are given in Table S3 . The library of bacteriophage-insensitive mutants (BIMs) and escape phage is shown 620 at the top (that is, Figure S1 ). For each CRISPR allele diversity treatment, the 621 relevant numbers of BIMs and escape phage were taken from the library and used to 622 start the experiment, as shown by the arrows. The number of BIMs is shown next to 623 the arrows. Blue text indicates that the BIM was engineered to carry a lacZ reporter 624 gene, and that it was susceptible to the escape phage. Black text indicates that the 625 BIMs were resistant to the phage. The number of replicates (N) is given underneath 626 each treatment. SM represents the surface mutant strain PA14 Table 3 Primers used to amplify and sequence the protospacers of interest of phage 644 that were shown to have undergone host shift (lost infectivity to the original clone 645 and could only infect a new clone) from the phenotypic assay. The first column 646 indicates if the protospacer was the original pre-evolved or the new protospacer, with 647 the identity of the protospacer shown in brackets. The primer sequence and binding 648 direction are shown, and if the primer was used for PCR or sequencing reactions. 649 Table 4 Protospacer sequences of evolved phage clones which showed host shift 650 according to the phenotypic assay from replicate 3 of the 24-clone treatment at 1 day 651 post-infection (dpi). The CRISPR-targeted protospacer and PAM sequences of the 652 ancestral (WT) phage and of the pre-evolved phage are shown. Numbers 1-12 are 653 separate phage isolates. The second column indicates if the protospacer was the 654 original pre-evolved or the new protospacer, with the identity of the protospacer 655
